Pfizer "MATISSE" Clinical Trial

2008 Pacific Ave, Long Beach CA

Description

Pfizer Clinical Trial to Evaluate The Efficacy And Safety Of A Respiratory Syncytial Virus (RSV) Vaccine In Infants Born to Women Vaccinated During Pregnancy • Respiratory syncytial virus is the most important cause of lower respiratory illness globally and effects the most vulnerable, killing nearly 120,000 children under 5 each year • Maternal vaccines give the mother antibodies which pass over the placenta to the child • We are looking for healthy maternal participants under 50 years old, 24-36 weeks along, that have uncomplicated singleton pregnancies. • The mother will participate in the study for about 3-4 months, and the infant will participate for 12 months • The mother will be compensated up to $1000 for participating in this study Learn more and see if you can take part at : https://rsvvaccinestudy.com/en-us/prescreener.html If interested, contact me or Long Beach Clinical Trials directly using the information listed below!